In earlier studies we also observed an association between (TGFbeta-induced) ECM remodeling during EMT and chemotherapy resistance in ovarian cancer [18], [79] as well as endocrine therapy resistance in breast cancer [80]–[82]. This evidence concerns the gene TGFB1 and ovarian cancer.